BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 7:26:00 PM | Browse: 1343 | Download: 1634
 |
Received |
|
2013-10-09 08:28 |
 |
Peer-Review Started |
|
2013-10-09 10:51 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2013-12-26 15:19 |
 |
Revised |
|
2014-01-27 23:25 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-03-13 13:58 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2014-03-13 16:36 |
 |
Articles in Press |
|
2014-05-23 11:08 |
 |
Edit the Manuscript by Language Editor |
|
2014-03-21 17:30 |
 |
Typeset the Manuscript |
|
2014-06-14 20:04 |
 |
Publish the Manuscript Online |
|
2014-07-14 17:39 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Topic Highlights |
| Article Title |
hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: A systematic review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Stina Nordh, Daniel Ansari and Roland Andersson |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Roland Andersson, MD, PhD, Department of Surgery, Clinical Sciences Lund, Lund University and Sk?ne University Hospital, Paradisgatan 2, SE-221 85 Lund, Sweden. roland.andersson@med.lu.se |
| Key Words |
Pancreatic cancer; Gemcitabine; hENT1; Predictive; Survival |
| Core Tip |
Human equilibrative nucleoside transporter 1 is a predictive marker for pancreatic cancer patients treated with gemcitabine. |
| Publish Date |
2014-07-14 17:39 |
| Citation |
Nordh S, Ansari D, Andersson R. hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: A systematic review. World J Gastroenterol 2014; 20(26): 8482-8490 |
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i26/8482.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i26.8482 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.